News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
High response rates in poor-risk population – Hagop Kantarjian
Photo of Dr. Hagop Kantarjian from obroncology.com
Jul 22, 2023, 17:56

High response rates in poor-risk population – Hagop Kantarjian

Our study of aza + ven + pevonedistat NEDD8-activating enzyme inhibitor in secondary AML & MDS/CMML after HMA failure. High response rates in poor-risk population. Data from randomized ph3 study in AML are awaited.

For article: Click here

Source: Hagop Kantarjian/Twitter

cancer Hagop Kantarjian Leukemia OncoDaily Oncology pevonedistat Research
Special Coverage
Science
Jan 16, 2025, 23:54
ESMO Global Consortium Study on the availability and accessibility of cancer medicines
Blog
Jan 16, 2025, 23:51
Tatiana Prowell: We don’t talk enough about the grief of caregiving for loved ones
Blog
Jan 16, 2025, 23:43
Gavi, the Vaccine Alliance - Celebrating a milestone in Ethiopia’s fight against cervical cancer
Blog
Jan 16, 2025, 23:41
European Medical Organisations Unite Against Health Workforce Crisis
Blog
Jan 16, 2025, 23:37
The first South East Europe Conference on HPV - European Cancer Organisation
Science
Jan 16, 2025, 23:35
Sami (Papacek) Mansfield: How long does it really take to build a habit?
Blog
Jan 16, 2025, 23:33
Jill Feldman: If I can help one person or one family - that matters
Blog
Jan 16, 2025, 23:27
The Basic Research in Cancer Health Disparities Program - NCI Center to Reduce Cancer Health Disparities
Blog
Jan 16, 2025, 23:24
Brittney Abernathy: I will be representing Frontiers in Nuclear Medicine at EMIM 2025
Blog
Jan 16, 2025, 23:23
Marina Uchenik: The annual Blue Faery Award for Excellence in Liver Cancer Research
Blog
Jan 16, 2025, 23:21
Jasmin Hundal: Career Development Day at Cleveland Clinic
Blog
Jan 16, 2025, 23:19
Psychopharmacology in Cancer Care: An Update for Clinicians of All Disciplines